Recent Advances in Antibody Therapy for Alzheimer's Disease: Focus on Bispecific Antibodies. — Alzheimer's disease (AD) impacts more than half a million people worldwide, with no cure available. The regulatory approval of three anti-amyloid monoclonal antibodies (mAbs), including aducanumab, lecanemab, and...

Evidence span

Recent Advances in Antibody Therapy for Alzheimer's Disease: Focus on Bispecific Antibodies. — Alzheimer's disease (AD) impacts more than half a million people worldwide, with no cure available. The regulatory approval of three anti-amyloid monoclonal antibodies (mAbs), including aducanumab, lecanemab, and...

From Yang HM 2025, International journal of molecular sciences

Method & conditions

Evidence type

experimental

Method

manual state transition; control details require source inspection

Species

Homo sapiens

Conditions

Blood-Brain Barrier; Animals; Humans; Alzheimer Disease; tau Proteins — International journal of molecular sciences 2025

Replicated

not yet

Confidence basis

operator-supplied frontier prior; review required